Skip to Main Content

Advertisement

Skip Nav Destination

Issues

EDITORIAL

J Immunol (2023) 211 (8): 1169–1170.

TOP READS

J Immunol (2023) 211 (8): 1171.

BRIEF REVIEWS

J Immunol (2023) 211 (8): 1173–1179.
J Immunol (2023) 211 (8): 1180–1186.
J Immunol (2023) 211 (8): 1187–1194.
J Immunol (2023) 211 (8): 1195–1201.

ANTIGEN RECOGNITION AND RESPONSES

J Immunol (2023) 211 (8): 1203–1215.

  • We investigated cross-presentation by APCs with homozygous KO for Sec22b and Stx4.

  • To our knowledge, this is the first study directly examining the role of Stx4 in cross-presentation.

  • KO of both Sec22b and Stx4 did not have major impact on the cross-presentation of tested Ags.

AUTOIMMUNITY

J Immunol (2023) 211 (8): 1216–1223.

  • Anti-NC16A IgEs recruit eosinophils in experimental BP through the eotaxin-1/CCR3 axis.

  • Eosinophil-derived MMP-9 mediates tissue injury in experimental BP.

  • The eotaxin-1/CCR3 axis and MMP-9 are candidate therapeutic targets in BP.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2023) 211 (8): 1224–1231.

  • Baseline Abs to respiratory viruses are lower with higher COVID-19 severity.

  • Abs to nonrespiratory viruses are not different between severity groups.

  • Titers to seasonal coronaviruses do not predict longitudinal SARS-CoV-2 titers.

IMMUNE REGULATION

J Immunol (2023) 211 (8): 1232–1239.

  • B. subtilis EPS inhibits Ag-specific T cell proliferation.

  • EPS induces inhibitory BMDCs by activating TLR4 and the IDO/kynurenine/AhR circuit.

  • TLR4 activation by EPS does not induce proinflammatory cytokines.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2023) 211 (8): 1240–1248.

  • The absence of sIgM is associated with increased anti-cardiolipin IgG levels.

  • Higher anti-cardiolipin IgG associates with worse injury in Adriamycin nephropathy.

  • IgG from female sIgM−/− mice binds to injured kidney cells.

CORRECTIONS

J Immunol (2023) 211 (8): 1249.

EXPRESSIONS OF CONCERN

J Immunol (2023) 211 (8): 1250.
J Immunol (2023) 211 (8): 1251.
Close Modal

or Create an Account

Close Modal
Close Modal